High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
- Author
- SCHULTE, Johannes H1 ; BACHMANN, Hagen S2 ; VANDESOMPELE, Jo3 ; SPELEMAN, Frank3 ; BERTHOLD, Frank4 ; EGGERT, Angelika1 ; BRORS, Benedikt6 ; HERO, Barbara4 ; SCHRAMM, Alexander1 ; FISCHER, Matthias4 ; BROCKMEYER, Bent1 ; DEPRETER, Katleen3 ; OBERTHÜR, André4 ; ACKERMANN, Sandra4 ; KAHLERT, Yvonne4 ; PAJTLER, Kristian1 ; THEISSEN, Jessica4 ; WESTERMANN, Frank5
[1] Department of Pediatric Oncology and Hematology, University Children's Hospital, Georgia
[2] Institute of Pharmacogenetics, University Hospital, Essen, Germany
[3] Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium
[4] Department of Pediatric Oncology and Hematology, University Children's Hospital, and Center for Molecular Medicine Cologne (CMMC), Cologne, Georgia
[5] Department of Tumor Genetics (B030), German Cancer Research Center, Georgia
[6] Department of Theoretical Bioinformatics (B080), German Cancer Research Center, Heidelberg, Germany - Source
Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 5082-5092, 11 p ; ref : 37 ref
- CODEN
- CCREF4
- ISSN
- 1078-0432
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- American Association for Cancer Research, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Expression génique Gène onc cellulaire Génétique Mutation Neuroblastome Phénotype Primaire Protooncogène Récepteur trk Anaplastic lymphoma kinase Cancer Pathologie du système nerveux sympathique Pathologie du système nerveux Tumeur maligne
- Keyword (en)
- Gene expression C-Onc gene Genetics Mutation Neuroblastoma Phenotype Primary Protooncogene trk receptor Anaplastic lymphoma kinase Cancer Autonomic neuropathy Nervous system diseases Malignant tumor
- Keyword (es)
- Expresión genética Gen onc celular Genética Mutación Neuroblastoma Fenotipo Primario Protooncogen Receptor trk Cáncer Sistema nervioso simpático patología Sistema nervioso patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17E Tumors of the nervous system. Phacomatoses
- Discipline
- Neurology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 24403773
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1158/1078-0432.CCR-10-2809 
https://dx.doi.org/10.1158/1078-0432.CCR-10-2809
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-10-2809\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Clinical cancer research (Print)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Clin. cancer res. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"17\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"5082\";s:8:\"\u0000*\u0000epage\";s:4:\"5092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCHULTE\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Johannes H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:17:\"BACHMANN, Hagen S\";i:1;s:16:\"VANDESOMPELE, Jo\";i:2;s:15:\"SPELEMAN, Frank\";i:3;s:15:\"BERTHOLD, Frank\";i:4;s:16:\"EGGERT, Angelika\";i:5;s:15:\"BRORS, Benedikt\";i:6;s:13:\"HERO, Barbara\";i:7;s:18:\"SCHRAMM, Alexander\";i:8;s:17:\"FISCHER, Matthias\";i:9;s:16:\"BROCKMEYER, Bent\";i:10;s:17:\"DEPRETER, Katleen\";i:11;s:17:\"OBERTH\u00dcR, Andr\u00e9\";i:12;s:17:\"ACKERMANN, Sandra\";i:13;s:15:\"KAHLERT, Yvonne\";i:14;s:17:\"PAJTLER, Kristian\";i:15;s:17:\"THEISSEN, Jessica\";i:16;s:17:\"WESTERMANN, Frank\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCREF4\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-10-2809\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Clinical cancer research (Print)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Clin. cancer res. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"17\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"5082\";s:8:\"\u0000*\u0000epage\";s:4:\"5092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCHULTE\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Johannes H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:17:\"BACHMANN, Hagen S\";i:1;s:16:\"VANDESOMPELE, Jo\";i:2;s:15:\"SPELEMAN, Frank\";i:3;s:15:\"BERTHOLD, Frank\";i:4;s:16:\"EGGERT, Angelika\";i:5;s:15:\"BRORS, Benedikt\";i:6;s:13:\"HERO, Barbara\";i:7;s:18:\"SCHRAMM, Alexander\";i:8;s:17:\"FISCHER, Matthias\";i:9;s:16:\"BROCKMEYER, Bent\";i:10;s:17:\"DEPRETER, Katleen\";i:11;s:17:\"OBERTH\u00dcR, Andr\u00e9\";i:12;s:17:\"ACKERMANN, Sandra\";i:13;s:15:\"KAHLERT, Yvonne\";i:14;s:17:\"PAJTLER, Kristian\";i:15;s:17:\"THEISSEN, Jessica\";i:16;s:17:\"WESTERMANN, Frank\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCREF4\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-10-2809\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-10-2809\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Clinical cancer research (Print)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Clin. cancer res. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"17\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"5082\";s:8:\"\u0000*\u0000epage\";s:4:\"5092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCHULTE\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Johannes H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:17:\"BACHMANN, Hagen S\";i:1;s:16:\"VANDESOMPELE, Jo\";i:2;s:15:\"SPELEMAN, Frank\";i:3;s:15:\"BERTHOLD, Frank\";i:4;s:16:\"EGGERT, Angelika\";i:5;s:15:\"BRORS, Benedikt\";i:6;s:13:\"HERO, Barbara\";i:7;s:18:\"SCHRAMM, Alexander\";i:8;s:17:\"FISCHER, Matthias\";i:9;s:16:\"BROCKMEYER, Bent\";i:10;s:17:\"DEPRETER, Katleen\";i:11;s:17:\"OBERTH\u00dcR, Andr\u00e9\";i:12;s:17:\"ACKERMANN, Sandra\";i:13;s:15:\"KAHLERT, Yvonne\";i:14;s:17:\"PAJTLER, Kristian\";i:15;s:17:\"THEISSEN, Jessica\";i:16;s:17:\"WESTERMANN, Frank\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCREF4\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-10-2809\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Clinical cancer research (Print)\";s:9:\"\u0000*\u0000stitle\";s:25:\"Clin. cancer res. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"17\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"5082\";s:8:\"\u0000*\u0000epage\";s:4:\"5092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SCHULTE\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Johannes H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:17:\"BACHMANN, Hagen S\";i:1;s:16:\"VANDESOMPELE, Jo\";i:2;s:15:\"SPELEMAN, Frank\";i:3;s:15:\"BERTHOLD, Frank\";i:4;s:16:\"EGGERT, Angelika\";i:5;s:15:\"BRORS, Benedikt\";i:6;s:13:\"HERO, Barbara\";i:7;s:18:\"SCHRAMM, Alexander\";i:8;s:17:\"FISCHER, Matthias\";i:9;s:16:\"BROCKMEYER, Bent\";i:10;s:17:\"DEPRETER, Katleen\";i:11;s:17:\"OBERTH\u00dcR, Andr\u00e9\";i:12;s:17:\"ACKERMANN, Sandra\";i:13;s:15:\"KAHLERT, Yvonne\";i:14;s:17:\"PAJTLER, Kristian\";i:15;s:17:\"THEISSEN, Jessica\";i:16;s:17:\"WESTERMANN, Frank\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CCREF4\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
